Similar articles for PMID: 33472986

Year	Number of Results
2000	1
2005	2
2006	2
2008	3
2009	2
2010	3
2011	5
2012	5
2013	10
2014	8
2015	11
2016	3
2017	9
2018	10
2019	17
2020	21
2021	5

1

Conservative Management of Alloimmune Hemolysis and Cholestasis With Extreme Laboratory Abnormalities.

Kotch C, Friedman DF, Wilkins BJ, Samelson-Jones BJ. Kotch C, et al. Pediatrics. 2021 Feb;147(2):e20193367. doi: 10.1542/peds.2019-3367. Pediatrics. 2021. PMID: 33472986

2

Conservative Management of Hyperferritinemia in Hemolytic Disease of the Fetus and Newborn: A Case Report and Review of the Literature.

Adam DL, Bowes L, Goodyear L, Moorehead PC. Adam DL, et al. J Pediatr Hematol Oncol. 2021 Mar 1;43(2):73-76. doi: 10.1097/MPH.0000000000001586. J Pediatr Hematol Oncol. 2021. PMID: 31460887

3

Cholestasis in neonates with red cell alloimmune hemolytic disease: incidence, risk factors and outcome.

Smits-Wintjens VE, Rath ME, Lindenburg IT, Oepkes D, van Zwet EW, Walther FJ, Lopriore E. Smits-Wintjens VE, et al. Neonatology. 2012;101(4):306-10. doi: 10.1159/000335333. Epub 2012 Feb 18. Neonatology. 2012. PMID: 22354012

4

Iron status in infants with alloimmune haemolytic disease in the first three months of life.

Rath ME, Smits-Wintjens VE, Oepkes D, Walther FJ, Lopriore E. Rath ME, et al. Vox Sang. 2013 Nov;105(4):328-33. doi: 10.1111/vox.12061. Epub 2013 Jun 27. Vox Sang. 2013. PMID: 23802744

5

Neonatal management and outcome in alloimmune hemolytic disease.

Ree IMC, Smits-Wintjens VEHJ, van der Bom JG, van Klink JMM, Oepkes D, Lopriore E. Ree IMC, et al. Expert Rev Hematol. 2017 Jul;10(7):607-616. doi: 10.1080/17474086.2017.1331124. Epub 2017 Jun 5. Expert Rev Hematol. 2017. PMID: 28503958 Review.

6

Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion.

Nwogu LC, Moise KJ Jr, Klein KL, Tint H, Castillo B, Bai Y. Nwogu LC, et al. Transfusion. 2018 Mar;58(3):677-684. doi: 10.1111/trf.14453. Epub 2017 Dec 17. Transfusion. 2018. PMID: 29250791

7

The Outcome of Hemolytic Disease of the Fetus and Newborn Caused by Anti-Rh17 Antibody: Analysis of Three Cases and Review of the Literature.

Dajak S, Ipavec N, Cuk M, Golubic Cepulic B, Mratinovic-Mikulandra J, Milardovic J, Stefanovic V. Dajak S, et al. Transfus Med Hemother. 2020 Jun;47(3):264-271. doi: 10.1159/000503012. Epub 2019 Oct 3. Transfus Med Hemother. 2020. PMID: 32595431 Free PMC article. Review.

8

Predicting anaemia and transfusion dependency in severe alloimmune haemolytic disease of the fetus and newborn in the first 3 months after birth.

Ree IMC, de Haas M, Middelburg RA, Zwiers C, Oepkes D, van der Bom JG, Lopriore E. Ree IMC, et al. Br J Haematol. 2019 Aug;186(4):565-573. doi: 10.1111/bjh.15962. Epub 2019 May 29. Br J Haematol. 2019. PMID: 31140599

9

Title: Effect of multiple maternal red cell alloantibodies on the occurrence and severity of Hemolytic Disease of the Fetus and Newborn.

Singh B, Chaudhary R, Katharia R. Singh B, et al. Transfus Apher Sci. 2020 Sep 23:102958. doi: 10.1016/j.transci.2020.102958. Online ahead of print. Transfus Apher Sci. 2020. PMID: 33039278

10

Diagnostic laboratory technologies for the fetus and neonate with isoimmunization.

Geaghan SM. Geaghan SM. Semin Perinatol. 2011 Jun;35(3):148-54. doi: 10.1053/j.semperi.2011.02.009. Semin Perinatol. 2011. PMID: 21641488 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed